FOXM1 and cancer: Because FOXM1 overexpression has been reported in cisplatin-resistant cancer cells [13,14], we next used qPCR to investigate the expression of FOXM1 mRNA in both the parental and cisplatin-resistant cell lines after 6 h treatment with cisplatin and/or paclitaxel (Figure 2A).